Opinion: Start now to prevent the next Purdue Pharma debacle
The judgment finalizing the Purdue Pharma bankruptcy case is a likely bitter end to litigation…
Category: Biotech
What will the Covid-19 booster roll out look like? Public health groups plan as they await details
Health agencies, providers, and other groups tasked with the herculean effort to vaccinate the public…
Tracking the FDA advisory panel meeting on Covid-19 booster shots
Do most Americans already need Covid-19 booster shots, or at least will they soon? Those…
Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial
Can prosthetic limbs feel real? Is the FDA softening under pressure? And are Rice Krispies…
New study revives a Mozart sonata as a potential epilepsy therapy
Could this be the return of the “Mozart effect”? In 1993, researchers reported that after…
DTx startup takes on a childhood eye disease & Jonathan Bush on the Cures Act
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
.jpg)
STAT+: Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal
Good morning, all, I hope everyone is off to a good start. Ed is out…
STAT+: Drug makers failed to block House provision cracking down on orphan drug tax credits
WASHINGTON — Drug makers mounted a last-minute, and so far unsuccessful, campaign to kill a surprise…
Opinion: STAT+: Rewriting the playbook for digital therapeutics
The acceleration of investment in digital health and adoption of health-related apps triggered by the…
Opinion: Beyond ‘vaccinopia’: Rapid tests should play a larger role in Biden’s Covid-19 plan
America is suffering from a serious case of vaccinopia: an inability to look beyond shots…
.jpg)
STAT+: A ‘wonky’ congressional report will be a pharma talking point in the drug pricing debate
As lawmakers in Washington grapple with legislation to alter the upward trajectory of prescription drug…
STAT+: Amgen combination treatment with KRAS-blocking drug shows improved response in colon cancer patients
A combination treatment that pairs Amgen’s KRAS-blocking drug Lumakras with another of its targeted cancer…
Black children have more complications during appendectomies and incur higher costs, study shows
Black children consistently have more medical complications during appendectomies than their white peers, including higher…
Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote
WASHINGTON — House Speaker Nancy Pelosi’s aggressive drug pricing package failed a key committee vote…
STAT+: Safety-net hospitals take big markups on cancer drugs for commercially insured patients, study finds
Hospitals participating in a federal drug discount program marked up cancer medicines four times for…
Opinion: Congress is about to legislate a future without new medicines. We have a better plan
One of the fundamental principles on which the U.S. economy is based is that the…
Storing donor lungs at warmer temperatures keeps them viable far longer, study finds
Storing donor lungs at a slightly warmer temperature – 10 degrees Celsius instead of 4…
STAT+: After a court let them off the hook, generic Zantac makers plan to seek legal expenses from consumers
A few months ago, a federal court judge dismissed all claims against more than a…
STAT+: Stanford spins out a company to tap old patient data to answer new questions
A company is launching out of Stanford University on Wednesday to tackle one of the…
FDA scientists strike skeptical tone on need for Covid-19 vaccine booster at this time, likely fueling debate
Food and Drug Administration scientists have expressed skepticism about the need for additional doses of…
Virtual Event: The 340B drug discount program is at a crossroads. What’s next?
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Moderate Democrats threaten House drug-pricing bill; FDA reverses decision on reviewing ALS drug
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Digital health measures are gaining traction, but research on privacy and ethics is lagging
A catalyzing new review found virtually no research into ethics, security, and data rights of…
STAT+: Facing pressure from ALS patients and advocates, the FDA does about-face on review of potential treatment
The Food and Drug Administration has reversed an internal decision and will now review an…
Opinion: Listen: An organizer and a physician on how climate change will worsen maternal health inequities
The country is in a climate crisis. California is experiencing its second-largest fire, on the…
Opinion: NIH needs to create a National Institute of Surgery
I recently received the 42nd grant rejection of my academic career, bringing my overall success…
STAT+: Key senator opposes Democrats’ target for drug-pricing savings
WASHINGTON — An influential Senate Democrat is pushing back against his party’s efforts to cut…
House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain
WASHINGTON — Three moderate House Democrats are making good on their threat to oppose Speaker…
Elizabeth Holmes trial set to resume, with more insider testimony
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: STAT+ Conversation: What’s next in gene therapy
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Purdue execs get their bonuses; Woodcock, two senators push patent office over pharma abuse
Top of the morning to you, and a fine one it is. The sun is…
Opinion: Aduhelm backlash threatens to reverse progress in FDA’s reviews of rare and ultra-rare disease drugs
The FDA’s approval of Aduhelm to treat Alzheimer’s disease has unleashed criticism about the decision…
Opinion: Medicine must ‘widen the doors’ to people of color
The pandemic and the death of George Floyd put a glaring spotlight on the gross…
Watch: After nearly dying in Iraq, a veteran volunteers for a surgical first to ‘help the next troops’
After barely surviving a bomb attack in Iraq in 2005, veteran Jerry Majetich lived with…
‘I can still feel it’: New arm amputation surgery makes a ‘phantom’ hand seem real
“Can you give me a thumbs up?” the surgeon asks Jerry Majetich, an Iraq War…
A conversation with Bill Gates on how public health has fared in the midst of the pandemic
The Covid-19 pandemic has, of course, been devastating over the past year. But by other…
test started free 2
Read Original Article: test started free 2 »
test started free
Read Original Article: test started free »
STAT+: FDA commissioner, two senators raise concerns about patent abuse by pharmaceutical companies
In a bid to address the high cost of medicines, Food and Drug Administration Commissioner…
STAT+: In new remarks, Cassava Sciences’ CEO shifts defense of embattled treatment for Alzheimer’s
Cassava Sciences CEO Remi Barbier on Monday shifted his defense of the company’s embattled treatment…
Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest
Harvard scientist George Church, a pioneer of both DNA sequencing and gene editing, has been…
STAT+: Pharmalittle: International experts argue against Covid-19 boosters; centrist House Dems to release separate drug-pricing proposal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
FDA vaccine regulators argue against Covid-19 vaccine boosters in new international review
A group of international experts — including, notably, two outgoing Food and Drug Administration vaccine…
STAT+: Cancer drug indications remain on labels even after trials fail to confirm their benefits
One-third of the uses for cancer drugs granted speedy approvals remained on product labeling even…
Opinion: STAT+: Combating the burnout bottleneck among clinical research workers
Health care professionals of all stripes were battling burnout and mental illness before the pandemic…
A vaccine veteran steps away from the NIH, looking out toward the world
In early January 2020, most of the world hadn’t yet awakened to the fact that…
STAT+: After a decade at Facebook and Google, a tech exec tries his hand at drug development
After building Facebook’s search bar into a pivotal part of its platform, Tom Stocky is…
Opinion: How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity
I’ve been a science reporter for 40 years. I’ve wanted to assume that the experts…
STAT+: Scientist Aubrey de Grey made inappropriate sexual comments to two female entrepreneurs, independent investigation finds
Aubrey de Grey, the anti-aging research pioneer who was removed last month as chief scientific…
STAT+: Biogen trials for Alzheimer’s drug excluded much of the targeted patient pool, study finds
A new analysis finds that the clinical trials conducted by Biogen (BIIB) for its controversial…